Rhythm Pharmaceuticals (RYTM) PT Increased From $136 to $143 at Wells Fargo on IMCIVREE Launch Optimism.
Share this article
Corporate
Score 45
Bullish
Rhythm Pharmaceuticals (RYTM) PT Increased From $136 to $143 at Wells Fargo on IMCIVREE Launch Optimism
Mar 18, 2026 21:16 UTC
RYTM
Short term
Related Articles
Score 65
Dongchedi, ByteDance-Backed Fintech, Names Citi, Goldman Sachs for Hong Kong IPO
Mar 20, 09:27
Score 85
Bullish
Fosun Secures $500 Million Refinancing Loan Amid Loss Warning
Mar 20, 08:52
Score 45
Vincorion's German IPO Sparks Share Gains Amid Defense Sector Interest
Mar 20, 08:25
Score 85
Unilever Looks to Offload $33 Billion Food Business to McCormick
Mar 20, 07:16
Stay Ahead of the Markets
Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.